K M Saari

Summary

Affiliation: University of Turku
Country: Finland

Publications

  1. ncbi Group II PLA(2) content of tears in normal subjects
    K M Saari
    Department of Ophthalmology, University of Turku, Turku, Finland
    Invest Ophthalmol Vis Sci 42:318-20. 2001
  2. ncbi Epidemiology of basal cell carcinoma of the eyelid in south-western Finland
    K M Saari
    Department of Ophthalmology, University of Turku, 20520 Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 239:230-3. 2001
  3. ncbi Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops
    Juha Matti Korte
    Department of Ophthalmology, University of Turku, Kiinamyllynkatu 4 8, 20520 Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 240:430-5. 2002
  4. ncbi Long-term results after treatment of basal cell carcinoma of the eyelid in South-Western Finland
    V Paavilainen
    Department of Ophthalmology, University of Turku, 20520 Turku, Finland
    Eur J Ophthalmol 17:494-500. 2007
  5. ncbi Group II phospholipase A2 content of tears in patients with senile cataract and primary open-angle glaucoma
    V V Aho
    Department of Ophthalmology, University of Turku, Finland
    Eur J Ophthalmol 12:40-3. 2002
  6. ncbi Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation
    K Matti Saari
    Department of Ophthalmology, University of Turku, Kiinamyllynkatu 4 8, 20520, Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 244:620-6. 2006

Collaborators

Detail Information

Publications6

  1. ncbi Group II PLA(2) content of tears in normal subjects
    K M Saari
    Department of Ophthalmology, University of Turku, Turku, Finland
    Invest Ophthalmol Vis Sci 42:318-20. 2001
    ..To determine the concentration of group II phospholipase (PL) A(2), an antimicrobial molecule, in tears of normal subjects in different age and sex groups...
  2. ncbi Epidemiology of basal cell carcinoma of the eyelid in south-western Finland
    K M Saari
    Department of Ophthalmology, University of Turku, 20520 Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 239:230-3. 2001
    ..Basal cell carcinoma (BCC) is the most common malignant tumour of the skin in Caucasians. It often appears on the eyelids but there are no population-based studies on the incidence of BCC of the eyelid in Nordic countries...
  3. ncbi Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops
    Juha Matti Korte
    Department of Ophthalmology, University of Turku, Kiinamyllynkatu 4 8, 20520 Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 240:430-5. 2002
    ..To investigate the pharmacological basis of systemic side effects of ophthalmic timolol, we estimated the systemic bioavailability of 0.5% timolol eyedrops and compared cardiopulmonary effects of intravenous and ophthalmic timolol...
  4. ncbi Long-term results after treatment of basal cell carcinoma of the eyelid in South-Western Finland
    V Paavilainen
    Department of Ophthalmology, University of Turku, 20520 Turku, Finland
    Eur J Ophthalmol 17:494-500. 2007
    ..The authors studied the clinical characteristics and the treatment results of BCC of the eyelid in southwestern Finland during 1977-1997...
  5. ncbi Group II phospholipase A2 content of tears in patients with senile cataract and primary open-angle glaucoma
    V V Aho
    Department of Ophthalmology, University of Turku, Finland
    Eur J Ophthalmol 12:40-3. 2002
    ..6+/-31.1 microg/ml in healthy controls. There were no significant differences between the patient and the control groups. CONCLUSIONS: We conclude that neither senile cataract nor POAG has any effect on the PLA2 content of tears...
  6. ncbi Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation
    K Matti Saari
    Department of Ophthalmology, University of Turku, Kiinamyllynkatu 4 8, 20520, Turku, Finland
    Graefes Arch Clin Exp Ophthalmol 244:620-6. 2006
    ..To compare 0.7% dexamethasone-cyclodextrin aqueous eye drop solution applied once daily with 0.1% dexamethasone sodium phosphate eye drops applied three times a day for the control of postoperative inflammation after cataract surgery...